


CeGaT Acquires Two Additional NovaSeq 6000 High-Throughput Sequencing Systems
Tübingen, Germany, April 11, 2022: CeGaT, a global provider…

Explore DNA Methylation on a Genome-Wide Scale
CeGaT expands its Research and Pharma Solutions product portfolio…


CeGaT receives DIN EN ISO 17025 accreditation from DAkkS
We are pleased to offer you NGS services accredited according…

The Diagnostic Panel for Metabolic Diseases and Mitochondriopathies has been updated and expanded
To increase clinical usability, the composition of the gene…


Study: Prenatal Trio Exome Sequencing Clarifies Ultrasound Abnormalities with a Solution Rate of 38%
Prenatal trio exome analysis is a highly sensitive method for…

Update and Extension of the Panel for Epilepsy and Brain Development Disorders
According to the latest clinical findings, we updated and expanded…
Genetic Diagnostics
Research & Pharma Solutions

CeGaT is a provider of genetic diagnostics and NGS services. The company is based in Tübingen, Germany and is accredited according to CAP, CLIA, DIN EN ISO 15189 and DIN EN ISO 17025.